SPRY3 and non-small cell lung carcinoma: lncRNA CRNDE/PRC2 targeting p21 sensitized radioresistance in NSCLC [37]; SPRY3-2/3/4 and H19–miR-130a-3p–WNK3 axis modulates radiosensitivity and affects apoptosis and cell viability in NSCLC [38,39].